Category Archives: Market News

Marapharm Ventures Inc. (MRPHF: OTCQB) | Marapharm Provides an Annual Corporate Update for 2017


KELOWNA, BC, Jan. 1, 2018 /CNW/ – Marapharm Ventures Inc. “Marapharm” announces achievements in 2017.

Marapharm Ventures Inc. (CNW Group/Marapharm Ventures Inc.)

2017 was a year of incredible growth for Marapharm. The corporate head office moved to a new larger location to accommodate its rapidly expanding business activities in Nevada, California, and Washington.

Shareholders expressed confidence in Marapharm and its future by exercising 22,547,420 warrants from January 19, 2017 to September 6, 2017 for proceeds totaling $11,035,252.00.

Directors, consultants, and employees also expressed their confidence in Marapharm by exercising 1,200,000 of their stock options for proceeds of $600,000.00.  In addition, Marapharm’s President purchased $500,00.00 of warrants and the directors purchased $300,000.00 of warrants totaling $800,000.00 worth of proceeds to Marapharm.

In May of 2017 the Company raised $1,748,480.00 through a USD Convertible Bond offering.

Marapharm provided a unique warrant offering investment opportunity to investors, a warrant offering, with a purchase price of $.010 per warrant, exercisable at $2.90 for a period of three years.  There was significant interest in the offering, therefore Marapharm has been closing the offering in tranches. To date 31,219,650 warrants have been subscribed totaling $3,121.965.00.  Marapharm has extended the offering to close the final tranche on January 31, 2018.

Market activity was strong in 2017 with increased trading volumes as follows:

FSE/Germany (2M0) traded 90,000,000 shares
OTC (MRPHF) traded 20,061,597 shares
CSE (MDM) traded 67,130,696 shares

Total volume for the 2017 trading year was 177,192,293 shares valued at approximately $200,000,000.00 Canadian.

Marapharm announced September 20, 2017 that it qualified and had been included in the CSE25 Index, a subgroup of the CSE Composite Index, comprised of the largest companies trading on the CSE. 

Marapharm announced April 19, 2017 that it was added to the United States Marijuana Index, which tracks the leading cannabis stocks trading on North American stock exchanges. The Index is a measure of the value of a section of the stock market. 

In August 2017, Marapharm was invited to apply to move its US trading from the OTCQB up to the OTCQX Best Markets.  Final approval was granted on December 26th, 2017 and trading will commence on this premier platform January 2, 2018.


On November 17, 2017, Marapharm was pleased to host an Open House event in Las Vegas at the Marapharm facility in which more than 300 attended to view the nearly-completed cultivation buildings. This gave shareholders and investors an opportunity to walk through the future cultivation centers and discuss with corporate directors the vision for Marapharm moving forward. A sod turning was performed at this event for the commencement of the next building, a 65,000 square foot, three story, cultivation and processing building.

Plans for this building were put out for bid in October of 2017, and Marapharm selected American Builders, located in Carson City, Nevada. Construction will begin immediately.

Cultivation began in two interim buildings with a focus on specific strains including; Kosher Kush, Grape God, Blueberry, Orient Express, Tangilope, Plum Crazy and Tangie. The focus will be to provide a premium quality organic product to the Nevada market.

One of the biggest accomplishments for the year, however, was the acquisition of 5 recreational marijuana licenses through the State Department of Taxation. These include 2 cultivation licenses, one production license, and 2 distribution licenses for a total of close to 300,000 square feet of licensing for recreational marijuana. Each one of these licenses now hold significant value in the current market.


Marapharm exercised the option to purchase 13.6 acres of land and buildings zoned for cannabis cultivation and production. Demolition of the building interior commenced and is now complete. Washington State imposed new energy guidelines during the year which required extensive insulation of the existing cultivation building. This is now complete and re-construction of the interior is scheduled for the new year. Cultivation in Washington will be directed by an award-winning cultivator and will focus on market specific strains.


During the year Marapharm bought and closed on two properties zoned for medical cannabis cultivation and production. These transactions provided the company with 4 medical marijuana licenses; 2 cultivation and 2 processing.

Subsequent to these purchases, Marapharm entered into an agreement to purchase a medical marijuana dispensary. The transaction is scheduled to complete in January, 2018.

The dispensary has received approval for a recreational marijuana dispensary license and is positioned to provide a venue for the taxable transactions required by California State law to apply for recreational licensing for all other licenses held by the Company in the State of California. On completion, this will allow the Company to hold 6 recreational licenses in California.


The Company continues to hold an application submitted to Health Canada for the purposes of cultivating and distributing medical marijuana. Additional information will be provided in regards to Marapharm’s staff profile, as well as details outlining the possibility of a new location.

There is a significant growth with the online presence evidenced by a 48% increase in visits to the site, as well as 544% new e-mail subscribers which now totals approximately 1500.

Marapharm started its own online TV show which airs daily via The purpose is to educate the public as to what is happening in the industry from different perspectives such as business, personal, and political while addressing current issues facing the cannabis industry. The website was developed and commenced with daily web updates on April 27th, 2017, adding daily shows on November 21st, 2017. A market report has also been integrated into the site to highlight Marapharm’s progress and provide information to shareholders and potential investors. The site has a growing demographic of loyal followers.

Veritas Pharma Inc.

Marapharm holds a total of 6,100,000 common shares of Veritas (a public company trading on: CSE: VRT; OTC: VRTHF; FSE: 2VP) representing approximately 15% in the share capital of the issuer, and assuming the exercise of the company’s total 11,500,000 warrants, Marapharm would hold a total of 17,600,000 common shares or approximately 32% of the issued and outstanding common shares of the issuer, Veritas Pharma Inc.  Marapharm invested in the company on January 9, 2017, January 11, 2017, and October 19, 2017.

The securities were acquired for investment and synergy purposes.

Other Business

Pursuant to the Company’s Restricted Stock Unit plan “RSU”, the shareholders and board voted to approve the issuance of 9,363,494 restricted stock units to directors, officers, consultants and staff for their contributions and vision which has enhanced Marapharm’s value for all shareholders and stakeholders.  In addition, the board approved the issuance of 2,500,000 stock options from its fixed stock option plan to directors, officers, consultants and staff.

“We’ve more than met our goals for 2017 and we’ve set even higher ones for 2018. Our entire team is more than ready for the new year that we believe will be filled with achievement! Based on assumptions that cannabis prices remain as they are and that we build out all the footage allowed for by the licenses we own, the projections are almost half a billion dollars of annual revenue for Marapharm. That is a milestone to reach for! The cannabis industry is exiting!” Linda Sampson, CEO.


Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include production locations in the key North American states of Washington, Nevada, and California. They actively seek expansion opportunities worldwide. 




Web Program:


Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, and in Europe, ticker symbol 2Mo on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L S, Quotnx, Dusseldorf, Munich, and Berlin. 

Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release. 


Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate. 

Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change.

Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm’s ability to access private and public capital could be affected and or could not be available to support continuing operations.

Marapharm’s business is conducted in a manner consistent with state law and is in compliance with licensing requirements.

Copies of licenses are posted on Marapharm’s website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US. 


Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.

SOURCE Marapharm Ventures Inc.

Article source:

Terra Tech Corp. (TRTC: OTCQX U.S.) | UPDATE

IRVINE, CA–(Marketwired – January 01, 2018) – Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that it has received State of California Temporary Authorization to distribute and retail cannabis, and expects to receive authorizations to cultivate and manufacture cannabis for California’s adult-use and medical markets, effective January 1, 2018. Terra Tech plans to commence adult-use cannabis sales to the California market immediately through its Blüm retail dispensaries located in Oakland and Santa Ana.

Terra Tech first started selling medical cannabis products to patients in California through its Blüm dispensary in Oakland. In anticipation of adult-use sales, the Company opened a second Blüm retail location in Santa Ana, California in September, 2017 and is currently constructing a Blüm dispensary in San Leandro, which is expected to open to the public in early 2018. The Company is also expanding its cultivation facilities through its ‘Craft Cultivation’ model, and has signed two craft cultivators, based in Honeydew and Salinas, to ramp production of the Company’s brand of premium cannabis. The Company’s IVXX cannabis is grown and harvested under the safest and most beneficial conditions, free of toxic pesticides, harmful molds and chemical residues. All products are rigorously tested and certified to the highest standards of potency and purity.

“California has the oldest medical cannabis program in the nation and has the largest population out of any state in America. This adult-use license allows us to significantly expand our potential customer base in California beyond the medical market,” commented Derek Peterson, Chief Executive Officer of Terra Tech. “Terra Tech is one of only a handful of companies that has been issued this adult-use license in time for the Jan 1st start date. We believe this first mover advantage will enable us to grow our brand and gain traction with new customers in what is expected to be the nation’s largest cannabis market. Over the past several months we have worked diligently to expand both our retail presence and our cultivation facilities to prepare us for this exciting opportunity and we look forward to capitalizing on our progress to grow sales and build value for shareholders.”

Once issued the State of California’s Temporary Authorization to conduct medical and adult cannabis retail sales, manufacturing, cultivation and distribution will be valid for 120 days and may be extended for an additional 90 days. This transition period, from January 1, 2018 through July 1, 2018, allows for existing operators to apply for their annual permits and affords the industry an opportunity to align all business operations with new state requirements. During this time period existing operators with local approval are authorized to retail the inventory on hand as of December 31, 2017, so long as it is appropriately labeled and in controlled packaging. Terra Tech is required to submit further information and documents related to each of its respective business entities to the State of California in order to secure annual adult-use and medical licenses, including but not limited to incorporation documents, business operational plans, financial information, and leadership/executive information, labor peace agreements for operations with more than 20 employees, along with proof of local approval to operate.

To be added to the Terra Tech email distribution list, please email with TRTC in the subject line.

About Terra Tech

Terra Tech Corp. (OTCQX: TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Blüm’s retail and medical cannabis facilities provide the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions as well as premium cannabis to the adult-use market in Nevada. Blüm offers a broad selection of cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces cannabis-extracted products for regulated medical cannabis dispensaries throughout California and medical and adult-use dispensaries in Nevada. The Company’s wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Winn-Dixie, Raley’s, Meijer, Kroger, Stop Shop and others nationwide. Terra Tech’s MediFarm LLC subsidiaries are focused on medical and adult-use cannabis cultivation and permitting businesses throughout Nevada.

For more information about Terra Tech Corp visit:
For more information about IVXX visit:
For more information about Blüm Nevada visit:
For more information about Blüm Oakland visit:
Visit us on Facebook @
Follow us on Twitter @terratechcorp
For more information about Edible Garden visit:
Visit Edible Garden on Facebook @
Visit IVXX on Facebook @

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Terra Tech Corp.’s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to Terra Tech Corp.’s (i) product demand, market and customer acceptance of its equipment and other goods, (ii) ability to obtain financing to expand its operations, (iii) ability to attract qualified sales representatives, (iv) competition, pricing and development difficulties, (v) ability to integrate GrowOp Technology Ltd. into its operations as a reporting issuer with the Securities and Exchange Commission, and (vi) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Terra Tech Corp.’s website does not constitute a part of this release.

Article source:

FirstAtlantic Financial Holdings Inc. (FFHD: OTCQX U.S. Premier) | National Commerce Corporation Announces Closing of Merger with FirstAtlantic Financial Holdings, Inc.

BIRMINGHAM, Ala., Jan. 01, 2018 (GLOBE NEWSWIRE) — National Commerce Corporation (Nasdaq:NCOM) (“NCC”), the parent company of National Bank of Commerce (“NBC”), headquartered in Birmingham, Alabama, announced today the completion of the merger of FirstAtlantic Financial Holdings, Inc. (OTCQX:FFHD) (“FirstAtlantic”), the parent company of FirstAtlantic Bank, with and into NCC.  Concurrently with the merger, FirstAtlantic Bank merged with and into NBC, but its offices will continue to operate under the “FirstAtlantic Bank” trade name, and its management team will continue with NBC.

“We are extremely pleased to partner with the team at FirstAtlantic,” said Richard Murray, IV, President and Chief Executive Officer of NCC.  “Mitch Hunt and his team have built a great bank, and we believe they are an excellent fit for our company.  We welcome the clients, shareowners and employees of FirstAtlantic Bank to NCC.  We look forward to working together with Mitch and Paul Grube as they lead our growth in the greater Jacksonville market.”

Mitchell W. Hunt, Jr., President and Chief Executive Officer of FirstAtlantic, also spoke about the merger, saying, “We are very pleased to join with our friends at NCC, and we look forward to our partnership.  We believe we will be in an even better position to serve our customers as a part of National Bank of Commerce.”

In connection with the merger, Thomas H. Coley, a director of FirstAtlantic and FirstAtlantic Bank, has been appointed to the Boards of Directors of both NCC and NBC.  Coley has previously served as Executive Vice President, Head of Southern Banking Group at Wachovia Corporation and as Vice Chairman of SouthTrust Corporation.

Keefe, Bruyette Woods, Inc. acted as financial adviser to NCC, and Maynard, Cooper Gale, P.C. acted as its legal adviser.  FIG Partners, LLC acted as financial adviser to FirstAtlantic, and Troutman Sanders LLP acted as its legal adviser. 

About National Commerce Corporation

National Commerce Corporation (Nasdaq:NCOM), a Delaware corporation, is a financial holding company headquartered in Birmingham, Alabama.  Substantially all of the operations of National Commerce Corporation are conducted through the company’s wholly owned subsidiary, National Bank of Commerce.  National Bank of Commerce currently operates seven full-service banking offices in Alabama, twenty-two full-service banking offices in central and northeast Florida (including under the trade names United Legacy Bank, Reunion Bank of Florida, Patriot Bank and FirstAtlantic Bank) and two full-service banking offices in the Atlanta, Georgia metro area (including under the trade names Private Bank of Buckhead, Private Bank of Decatur and PrivatePlus Mortgage).  National Bank of Commerce provides a broad array of financial services for commercial and consumer customers.

Additionally, National Bank of Commerce owns a majority stake in Corporate Billing, LLC, a transaction-based finance company based in Decatur, Alabama that provides factoring, invoicing, collection and accounts receivable management services to transportation companies and automotive parts and service providers throughout the United States and parts of Canada.

National Commerce Corporation files periodic reports with the U.S. Securities and Exchange Commission (the “SEC”).  Copies of its filings may be obtained through the SEC’s website at or at  More information about National Commerce Corporation and National Bank of Commerce may be obtained at

Forward-Looking Statements

Certain statements contained in this press release that are not statements of historical fact constitute forward-looking statements for which NCC claims the protection of the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995 (the “Act”), notwithstanding that such statements are not specifically identified as such.  In addition, certain statements may be contained in NCC’s future filings with the SEC, in press releases and in oral and written statements made by NCC or with NCC’s approval that are not statements of historical fact and that constitute forward-looking statements within the meaning of the Act.  Words such as “believes,” “anticipates,” “expects,” “intends,” “targeted,” “continue,” “remain,” “will,” “should,” “may” and other similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.

Forward-looking statements (including oral representations) involve risks and uncertainties that may cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.  These risks and uncertainties include difficulties, delays and unanticipated costs in integrating NBC’s and FirstAtlantic Bank’s businesses or realizing expected cost savings and other benefits; business disruptions as a result of the integration of the merging organizations, including possible loss of customers; diversion of management time to address transaction-related issues; and changes in asset quality and credit risk as a result of the merger.  These risks also include a number of factors related to the business of NCC and the banking business generally, including various risks to stockholders of not receiving dividends; risks to NCC’s ability to pursue growth opportunities; various risks to the price and volatility of NCC’s common stock; NCC’s ability to incur additional financial obligations in the future; risks associated with NCC’s possible pursuit of future acquisitions; economic conditions in NCC’s current service areas, including the new service areas created by the merger; system failures; losses of large customers; disruptions in relationships with third-party vendors; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; changes in the extensive governmental legislation and regulations governing banking; high costs of regulatory compliance; the impact of legislation and regulatory changes, including changes in the tax laws, on the banking industry; and liability and compliance costs regarding banking regulations.

Forward-looking statements made by NCC in this press release or elsewhere speak only as of the date on which the statements were made.  You are advised to read the risk factors in NCC’s most recently filed Annual Report on Form 10-K and subsequent filings with the SEC, which are available through the website maintained by the SEC at or by accessing information available at  New risks and uncertainties arise from time to time, and it is impossible for NCC to predict these events or how they may affect it or its anticipated results.  NCC has no duty to, and does not intend to, update or revise the forward-looking statements in this press release, except as may be required by law.  In light of these risks and uncertainties, readers should keep in mind that any forward-looking statement made in this press release may not occur.  All information presented herein is as of the date of this release unless otherwise noted.

Contact Information

Richard Murray, IV                                                    
President and Chief Executive Officer                       
National Commerce Corporation                                                        
(205) 313-8100

Primary Logo

Article source:

Bunk Beds